Dystonia in corticobasal degeneration
OBJECTIVE: To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal degeneration (CBD). BACKGROUND: Although dystonia has been reported in many neurodegenerative disorders, it has not been studied in CBD. Dystonia, ofte...
Saved in:
Published in | Movement disorders Vol. 16; no. 2; pp. 252 - 257 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
New York
John Wiley & Sons, Inc
01.03.2001
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | OBJECTIVE:
To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal degeneration (CBD).
BACKGROUND:
Although dystonia has been reported in many neurodegenerative disorders, it has not been studied in CBD. Dystonia, often accompanied by painful rigidity and fixed contractures, is one of the most disabling features of CBD.
METHODS:
The medical records, imaging studies, and videotapes of 66 patients who satisfied the clinical criteria of CBD, evaluated between 1988 and 1998, were reviewed. The occurrence, nature, and distribution of dystonic features were analyzed and correlated with other features of CBD.
RESULTS:
Of the 66 patients with CBD, 39 (59.0%) had dystonia. The mean age at onset of initial symptoms was 63.9 years (range 44–75). In 20 (51.0%) patients, dystonic symptoms began in one arm, while 13 (33.0%) patients had initial leg involvement. At least one arm was affected in 36 (92.0%) dystonic patients. Although 11 (28.0%) patients had leg dystonia, the leg was the predominant site of involvement in only 1 patient. Only 12 (31.0%) patients had dystonia involving the head, neck, or trunk in the course of the disease. The diagnosis of CBD was confirmed in all 4 patients who had autopsies.
CONCLUSION:
In this large series of CBD patients we found that asymmetric limb dystonia, particularly affecting one arm, is a common manifestation of CBD; dystonia may be the initial manifestation of this neurodegenerative disorder. Axial or leg dystonia, without significant involvement of an arm, is rare. There is no effective treatment for this relentless disorder, except for temporary relief of dystonia and pain, with local botulinum toxin injections. © 2001 Movement Disorder Society. |
---|---|
AbstractList | Abstract
OBJECTIVE:
To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal degeneration (CBD).
BACKGROUND:
Although dystonia has been reported in many neurodegenerative disorders, it has not been studied in CBD. Dystonia, often accompanied by painful rigidity and fixed contractures, is one of the most disabling features of CBD.
METHODS:
The medical records, imaging studies, and videotapes of 66 patients who satisfied the clinical criteria of CBD, evaluated between 1988 and 1998, were reviewed. The occurrence, nature, and distribution of dystonic features were analyzed and correlated with other features of CBD.
RESULTS:
Of the 66 patients with CBD, 39 (59.0%) had dystonia. The mean age at onset of initial symptoms was 63.9 years (range 44–75). In 20 (51.0%) patients, dystonic symptoms began in one arm, while 13 (33.0%) patients had initial leg involvement. At least one arm was affected in 36 (92.0%) dystonic patients. Although 11 (28.0%) patients had leg dystonia, the leg was the predominant site of involvement in only 1 patient. Only 12 (31.0%) patients had dystonia involving the head, neck, or trunk in the course of the disease. The diagnosis of CBD was confirmed in all 4 patients who had autopsies.
CONCLUSION:
In this large series of CBD patients we found that asymmetric limb dystonia, particularly affecting one arm, is a common manifestation of CBD; dystonia may be the initial manifestation of this neurodegenerative disorder. Axial or leg dystonia, without significant involvement of an arm, is rare. There is no effective treatment for this relentless disorder, except for temporary relief of dystonia and pain, with local botulinum toxin injections. © 2001 Movement Disorder Society. OBJECTIVE: To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal degeneration (CBD). BACKGROUND: Although dystonia has been reported in many neurodegenerative disorders, it has not been studied in CBD. Dystonia, often accompanied by painful rigidity and fixed contractures, is one of the most disabling features of CBD. METHODS: The medical records, imaging studies, and videotapes of 66 patients who satisfied the clinical criteria of CBD, evaluated between 1988 and 1998, were reviewed. The occurrence, nature, and distribution of dystonic features were analyzed and correlated with other features of CBD. RESULTS: Of the 66 patients with CBD, 39 (59.0%) had dystonia. The mean age at onset of initial symptoms was 63.9 years (range 44-75). In 20 (51.0%) patients, dystonic symptoms began in one arm, while 13 (33.0%) patients had initial leg involvement. At least one arm was affected in 36 (92.0%) dystonic patients. Although 11 (28.0%) patients had leg dystonia, the leg was the predominant site of involvement in only 1 patient. Only 12 (31.0%) patients had dystonia involving the head, neck, or trunk in the course of the disease. The diagnosis of CBD was confirmed in all 4 patients who had autopsies. CONCLUSION: In this large series of CBD patients we found that asymmetric limb dystonia, particularly affecting one arm, is a common manifestation of CBD; dystonia may be the initial manifestation of this neurodegenerative disorder. Axial or leg dystonia, without significant involvement of an arm, is rare. There is no effective treatment for this relentless disorder, except for temporary relief of dystonia and pain, with local botulinum toxin injections. OBJECTIVE: To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal degeneration (CBD). BACKGROUND: Although dystonia has been reported in many neurodegenerative disorders, it has not been studied in CBD. Dystonia, often accompanied by painful rigidity and fixed contractures, is one of the most disabling features of CBD. METHODS: The medical records, imaging studies, and videotapes of 66 patients who satisfied the clinical criteria of CBD, evaluated between 1988 and 1998, were reviewed. The occurrence, nature, and distribution of dystonic features were analyzed and correlated with other features of CBD. RESULTS: Of the 66 patients with CBD, 39 (59.0%) had dystonia. The mean age at onset of initial symptoms was 63.9 years (range 44–75). In 20 (51.0%) patients, dystonic symptoms began in one arm, while 13 (33.0%) patients had initial leg involvement. At least one arm was affected in 36 (92.0%) dystonic patients. Although 11 (28.0%) patients had leg dystonia, the leg was the predominant site of involvement in only 1 patient. Only 12 (31.0%) patients had dystonia involving the head, neck, or trunk in the course of the disease. The diagnosis of CBD was confirmed in all 4 patients who had autopsies. CONCLUSION: In this large series of CBD patients we found that asymmetric limb dystonia, particularly affecting one arm, is a common manifestation of CBD; dystonia may be the initial manifestation of this neurodegenerative disorder. Axial or leg dystonia, without significant involvement of an arm, is rare. There is no effective treatment for this relentless disorder, except for temporary relief of dystonia and pain, with local botulinum toxin injections. © 2001 Movement Disorder Society. To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal degeneration (CBD). Although dystonia has been reported in many neurodegenerative disorders, it has not been studied in CBD. Dystonia, often accompanied by painful rigidity and fixed contractures, is one of the most disabling features of CBD. The medical records, imaging studies, and videotapes of 66 patients who satisfied the clinical criteria of CBD, evaluated between 1988 and 1998, were reviewed. The occurrence, nature, and distribution of dystonic features were analyzed and correlated with other features of CBD. Of the 66 patients with CBD, 39 (59.0%) had dystonia. The mean age at onset of initial symptoms was 63.9 years (range 44--75). In 20 (51.0%) patients, dystonic symptoms began in one arm, while 13 (33.0%) patients had initial leg involvement. At least one arm was affected in 36 (92.0%) dystonic patients. Although 11 (28.0%) patients had leg dystonia, the leg was the predominant site of involvement in only 1 patient. Only 12 (31.0%) patients had dystonia involving the head, neck, or trunk in the course of the disease. The diagnosis of CBD was confirmed in all 4 patients who had autopsies. In this large series of CBD patients we found that asymmetric limb dystonia, particularly affecting one arm, is a common manifestation of CBD; dystonia may be the initial manifestation of this neurodegenerative disorder. Axial or leg dystonia, without significant involvement of an arm, is rare. There is no effective treatment for this relentless disorder, except for temporary relief of dystonia and pain, with local botulinum toxin injections. |
Author | Jankovic, Joseph Vanek, Zeba |
Author_xml | – sequence: 1 givenname: Zeba surname: Vanek fullname: Vanek, Zeba organization: Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA – sequence: 2 givenname: Joseph surname: Jankovic fullname: Jankovic, Joseph organization: Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, USA |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1032468$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11295777$$D View this record in MEDLINE/PubMed |
BookMark | eNp10M1LwzAYBvAgivtQ8C-QHVS8VJOm-Trq5qYwFXHgMaRpItE2nUmH7r-3Y0W9eHrfw4_ngWcAdn3tDQBHCF4gCNPLqojtg_kO6COCUcJTwnZBH3JOEow46YFBjG8QIkQQ3Qc9hFJBGGN9cDpZx6b2To2cH-k6NE7XuYqqHBXm1XgTVONqfwD2rCqjOezuECymN4vxbTJ_nN2Nr-aJzjjiCRc4oxlkJLcGG6oFhlAgBXkGtcptlgsFaVvLERW0IEZbmGIjLLVUZMziITjbxi5D_bEysZGVi9qUpfKmXkWZIkQpZbSF51uoQx1jMFYug6tUWEsE5WYR2S4iN4u09LjLXOWVKX5hN0ELTjqgolalDcprF_8E4jSjm5xkyz5dadb_9sn7yXPX23kXG_P141V4l5RhRuTLw0xOp0xcP01mEuJvJE6FUQ |
CitedBy_id | crossref_primary_10_1038_nrneurol_2016_14 crossref_primary_10_1590_0004_282x20170077 crossref_primary_10_1097_00019052_200208000_00014 crossref_primary_10_1111_j_1468_1331_2006_01650_x crossref_primary_10_1212_WNL_0b013e31827f0fd1 crossref_primary_10_1016_j_emcn_2003_10_006 crossref_primary_10_1016_S1474_4422_06_70547_6 crossref_primary_10_1002_mds_21141 crossref_primary_10_1007_s11940_013_0282_1 crossref_primary_10_1016_j_jns_2008_10_005 crossref_primary_10_1016_j_parkreldis_2019_07_030 crossref_primary_10_1111_j_1468_1331_2010_03046_x crossref_primary_10_1007_s00115_008_2559_2 crossref_primary_10_2217_nmt_13_1 crossref_primary_10_1002_mds_20458 crossref_primary_10_1016_j_pjnns_2017_11_004 crossref_primary_10_1002_mds_20794 crossref_primary_10_1002_mds_24992 crossref_primary_10_3389_fnins_2024_1371601 crossref_primary_10_1002_mds_10563 crossref_primary_10_1007_s00702_019_01986_1 crossref_primary_10_1016_j_jocn_2011_10_012 crossref_primary_10_3390_life12020206 crossref_primary_10_1007_s00415_018_9049_7 crossref_primary_10_1016_S0246_0378_04_75776_0 crossref_primary_10_1016_j_jocn_2015_11_025 crossref_primary_10_3389_fneur_2017_00170 crossref_primary_10_1002_mds_22090 crossref_primary_10_3390_ijms241613006 crossref_primary_10_1016_S1474_4422_05_70119_8 crossref_primary_10_3238_arztebl_2016_0061 crossref_primary_10_1007_s11940_003_0006_z crossref_primary_10_3389_fneur_2021_661130 crossref_primary_10_1016_j_jns_2005_08_004 crossref_primary_10_1002_mds_21578 crossref_primary_10_1007_s00702_023_02691_w crossref_primary_10_1002_mds_21058 crossref_primary_10_1002_mds_21992 crossref_primary_10_1016_j_jns_2015_04_023 |
Cites_doi | 10.1007/BF00662643 10.1093/brain/112.5.1171 10.1093/brain/117.5.1197 10.1001/archneur.1968.00470310034003 10.1007/978-3-7091-6641-3_7 10.1212/WNL.53.9.1969 10.1111/jon199664222 10.1002/1531-8257(200003)15:2<340::AID-MDS1025>3.0.CO;2-O 10.1002/mds.870120315 10.1136/jnnp.64.2.184 10.1212/WNL.40.8.1203 10.1001/archneur.55.7.957 10.1002/mds.870050420 10.1093/brain/114.1.541 10.1093/brain/108.1.193 10.1212/WNL.48.4.959 10.1002/mds.870120419 10.1136/jnnp.55.9.806 10.1212/WNL.40.10.1571 10.1212/WNL.46.3.720 10.1093/brain/117.5.1183 10.1016/0022-510X(90)90271-N |
ContentType | Journal Article |
Copyright | Copyright © 2001 Movement Disorder Society 2001 INIST-CNRS Copyright 2001 Movement Disorder Society. |
Copyright_xml | – notice: Copyright © 2001 Movement Disorder Society – notice: 2001 INIST-CNRS – notice: Copyright 2001 Movement Disorder Society. |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK |
DOI | 10.1002/mds.1038 |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Neurosciences Abstracts |
DatabaseTitleList | CrossRef Neurosciences Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1531-8257 |
EndPage | 257 |
ExternalDocumentID | 10_1002_mds_1038 11295777 1032468 MDS1038 ark_67375_WNG_FF79BQDG_0 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1CY 1L6 1OB 1OC 1ZS 31~ 33P 3PY 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVGM AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFVGU AFZJQ AGJLS AHBTC AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC FYBCS G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWD RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 YCJ ZGI ZZTAW ~IA ~WT AITYG HGLYW OIG AAPBV IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK |
ID | FETCH-LOGICAL-c4818-893464075bfe3e6c930091a0840cabf4b9a0677781696d5ecf023e9f6f6947f3 |
IEDL.DBID | DR2 |
ISSN | 0885-3185 |
IngestDate | Fri Aug 16 01:03:24 EDT 2024 Fri Aug 23 02:07:01 EDT 2024 Sat Sep 28 07:36:16 EDT 2024 Sun Oct 22 16:06:00 EDT 2023 Sat Aug 24 01:10:04 EDT 2024 Wed Jan 17 05:06:25 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Human Nervous system diseases Cerebral cortex Exploration Basal ganglion Cerebral disorder Involuntary movement Symptomatology Striated muscle disease Central nervous system disease Distribution Adult Degenerative disease Degeneration Diagnosis Dystonia Neurological disorder Extrapyramidal syndrome |
Language | English |
License | CC BY 4.0 Copyright 2001 Movement Disorder Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4818-893464075bfe3e6c930091a0840cabf4b9a0677781696d5ecf023e9f6f6947f3 |
Notes | istex:D70AD2E0B7131CB2C8F7919BE918365D2076C56E ArticleID:MDS1038 ark:/67375/WNG-FF79BQDG-0 A videotape accompanies this article. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 11295777 |
PQID | 21166676 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_21166676 crossref_primary_10_1002_mds_1038 pubmed_primary_11295777 pascalfrancis_primary_1032468 wiley_primary_10_1002_mds_1038_MDS1038 istex_primary_ark_67375_WNG_FF79BQDG_0 |
PublicationCentury | 2000 |
PublicationDate | March 2001 |
PublicationDateYYYYMMDD | 2001-03-01 |
PublicationDate_xml | – month: 03 year: 2001 text: March 2001 |
PublicationDecade | 2000 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: Hoboken, NJ – name: United States |
PublicationTitle | Movement disorders |
PublicationTitleAlternate | Mov. Disord |
PublicationYear | 2001 |
Publisher | John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley |
References | Paulus W, Selim M. Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol (Berl) 1990;81:89-94. Tanner CM. Epidemiologic approaches to cortical-basal ganglionic degeneration. Mov Disord 1996;11:346-357. Rivest J, Quinn N, Marsden CD. Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology 1990;40:1571-1578. Litvan I, Agid Y, Goetz CG, Jankovic J, et al. Validity of clinical diagnosis of cortical-basal ganglionic degeneration. Mov Disord 1996;11:354-355. Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999;53:1969-1974. Hauser RA, Murtaugh FR, Akhter K, Gold M, Olanow CW. Magnetic resonance imaging of corticobasal degeneration. J Neuroimaging 1996;6:222-226. Lippa CF, Smith TW, Fontneau N. Corticonigral degeneration with neuronal achromasia. A clinicopathologic study of two cases. J Neurol Sci 1990;98:301-310. Doody RS, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry 1992;55:806-810. Strafella A, Ashby P, Lang AE. Reflex myoclonus in cortical-basal ganglionic degeneration involves a transcortical pathway. Mov Disord 1997;12:360-369. Lindholm KM, Shannon KM, Stebbins GT. A comparison of apraxia in Progressive supranuclear palsy and corticobasal ganglionic degeneration. Mov Disord 1996;11:3:346-357. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998;64:184-189. Vanek Z, Jankovic J. Dystonia in corticobasal degeneration. Adv Neurol 2000;82:61-67. Kompoliti K, Goetz CG, Boeve BF, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 1998;55:957-961. Schneider JA, Watts RL, Gearing M, et al. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997;48:599-969. Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246(suppl 2):1-5. Gibb WRG, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-1192. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33. Gimenez-Roldan S, Mateo D, Benito C, et al. Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. J Neural Transm 1994;42:79-90. Frucht S, Fahn S, Chin S, Dhawan V, Eidelberg D. Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration. Mov Disord 2000;15:340-343. Caselli RJ. Focal and asymmetric cortical degenerative syndromes. Adv Neurol 2000;82:35-51. Riley DE, Lang AE, Lewis A, et al. Corticobasal ganglionic degeneration. Neurology 1990;40:1203-1212. Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in corticobasal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology 1996;36:720-726. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration: a clinical study of 36 cases. Brain 1994;117:1183-1196. Obeso JA, Rothwell JC, Marsden CD. The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy. Brain 1985;108:193-224. Greene PE, Fahn S. What is it? Case 1, 1990. Progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb. Mov Disord 1990;5:341-351. Hanna PA, Doody RS. Alien limb sign. Adv Neurol 2000;82:135-45 Thompson PD, Day BL, Rothwell JC, et al. The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 1994;117:1197-1208. Ashby P, Strafella A, Lang A. Cortical-basal ganglia degeneration. Neurophysiology of stimulus-sensitive myoclonus. Mov Disord 1996;11:346-357. Carella F, Ciano C, Panzica F, Scaioli V. Myoclonus in cortical-basal ganglionic degeneration. Mov Disord 1997;12:598-603. Sawle GV, Brooks DJ, Marsden CD, Frackowiak RS. Corticobasal degeneration: a unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991;114:541-556. 1990; 40 1990; 98 1968; 18 1991; 114 1994; 117 1989; 112 2000; 15 1997; 48 1997; 12 1998 2000; 82 1994 1999; 53 1999; 246 1985; 108 1996; 36 1992; 55 1998; 64 1998; 55 1990; 81 1990; 5 1996; 6 1996; 11 1994; 42 Litvan I (e_1_2_6_27_2) 1999; 246 e_1_2_6_31_2 Vanek Z (e_1_2_6_12_2) 2000; 82 Jankovic J (e_1_2_6_7_2) 1998 Tanner CM (e_1_2_6_13_2) 1996; 11 e_1_2_6_18_2 e_1_2_6_19_2 Hanna PA (e_1_2_6_29_2) 2000; 82 e_1_2_6_34_2 e_1_2_6_10_2 e_1_2_6_33_2 e_1_2_6_11_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 e_1_2_6_20_2 Litvan I (e_1_2_6_3_2) 1996; 11 Kumar R (e_1_2_6_9_2) 1998 e_1_2_6_8_2 e_1_2_6_4_2 Lang AE (e_1_2_6_6_2) 1994 e_1_2_6_5_2 e_1_2_6_24_2 Lindholm KM (e_1_2_6_30_2) 1996; 11 e_1_2_6_2_2 e_1_2_6_22_2 Caselli RJ (e_1_2_6_32_2) 2000; 82 e_1_2_6_21_2 e_1_2_6_28_2 Ashby P (e_1_2_6_23_2) 1996; 11 e_1_2_6_26_2 e_1_2_6_25_2 |
References_xml | – volume: 42 start-page: 79 year: 1994 end-page: 90 article-title: Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques publication-title: J Neural Transm – volume: 11 start-page: 354 year: 1996 end-page: 355 article-title: Validity of clinical diagnosis of cortical‐basal ganglionic degeneration publication-title: Mov Disord – volume: 82 start-page: 135 year: 2000 end-page: 45 article-title: Alien limb sign publication-title: Adv Neurol – volume: 53 start-page: 1969 year: 1999 end-page: 1974 article-title: Dementia as the most common presentation of cortical‐basal ganglionic degeneration publication-title: Neurology – volume: 12 start-page: 598 year: 1997 end-page: 603 article-title: Myoclonus in cortical‐basal ganglionic degeneration publication-title: Mov Disord – volume: 81 start-page: 89 year: 1990 end-page: 94 article-title: Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles publication-title: Acta Neuropathol (Berl) – volume: 112 start-page: 1171 year: 1989 end-page: 1192 article-title: Corticobasal degeneration publication-title: Brain – volume: 117 start-page: 1183 year: 1994 end-page: 1196 article-title: Corticobasal degeneration: a clinical study of 36 cases publication-title: Brain – volume: 11 start-page: 346 year: 1996 end-page: 357 article-title: Epidemiologic approaches to cortical‐basal ganglionic degeneration publication-title: Mov Disord – volume: 246 start-page: 1 issue: suppl 2 year: 1999 end-page: 5 article-title: Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration publication-title: J Neurol – start-page: 513 year: 1998 end-page: 551 – volume: 36 start-page: 720 year: 1996 end-page: 726 article-title: Neuropsychological functioning in corticobasal ganglionic degeneration: differentiation from Alzheimer's disease publication-title: Neurology – volume: 55 start-page: 957 year: 1998 end-page: 961 article-title: Clinical presentation and pharmacological therapy in corticobasal degeneration publication-title: Arch Neurol – volume: 108 start-page: 193 year: 1985 end-page: 224 article-title: The spectrum of cortical myoclonus. From focal reflex jerks to spontaneous motor epilepsy publication-title: Brain – volume: 40 start-page: 1203 year: 1990 end-page: 1212 article-title: Corticobasal ganglionic degeneration publication-title: Neurology – volume: 5 start-page: 341 year: 1990 end-page: 351 article-title: What is it? Case 1, 1990. Progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb publication-title: Mov Disord – volume: 55 start-page: 806 year: 1992 end-page: 810 article-title: The alien hand and related signs publication-title: J Neurol Neurosurg Psychiatry – volume: 98 start-page: 301 year: 1990 end-page: 310 article-title: Corticonigral degeneration with neuronal achromasia. A clinicopathologic study of two cases publication-title: J Neurol Sci – volume: 11 start-page: 346 issue: 3 year: 1996 end-page: 357 article-title: A comparison of apraxia in Progressive supranuclear palsy and corticobasal ganglionic degeneration publication-title: Mov Disord – volume: 64 start-page: 184 year: 1998 end-page: 189 article-title: Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination publication-title: J Neurol Neurosurg Psychiatry – start-page: 877 year: 1994 end-page: 894 – volume: 40 start-page: 1571 year: 1990 end-page: 1578 article-title: Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy publication-title: Neurology – volume: 48 start-page: 599 year: 1997 end-page: 969 article-title: Corticobasal degeneration: neuropathologic and clinical heterogeneity publication-title: Neurology – volume: 117 start-page: 1197 year: 1994 end-page: 1208 article-title: The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus publication-title: Brain – volume: 12 start-page: 360 year: 1997 end-page: 369 article-title: Reflex myoclonus in cortical‐basal ganglionic degeneration involves a transcortical pathway publication-title: Mov Disord – volume: 114 start-page: 541 year: 1991 end-page: 556 article-title: Corticobasal degeneration: a unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography publication-title: Brain – volume: 82 start-page: 35 year: 2000 end-page: 51 article-title: Focal and asymmetric cortical degenerative syndromes publication-title: Adv Neurol – start-page: 297 year: 1998 end-page: 316 – volume: 11 start-page: 346 year: 1996 end-page: 357 article-title: Cortical‐basal ganglia degeneration. Neurophysiology of stimulus‐sensitive myoclonus publication-title: Mov Disord – volume: 6 start-page: 222 year: 1996 end-page: 226 article-title: Magnetic resonance imaging of corticobasal degeneration publication-title: J Neuroimaging – volume: 15 start-page: 340 year: 2000 end-page: 343 article-title: Levodopa‐induced dyskinesias in autopsy‐proven cortical‐basal ganglionic degeneration publication-title: Mov Disord – volume: 18 start-page: 20 year: 1968 end-page: 33 article-title: Corticodentatonigral degeneration with neuronal achromasia publication-title: Arch Neurol – volume: 82 start-page: 61 year: 2000 end-page: 67 article-title: Dystonia in corticobasal degeneration publication-title: Adv Neurol – start-page: 877 volume-title: Neurodegenerative diseases year: 1994 ident: e_1_2_6_6_2 contributor: fullname: Lang AE – ident: e_1_2_6_19_2 doi: 10.1007/BF00662643 – ident: e_1_2_6_16_2 doi: 10.1093/brain/112.5.1171 – ident: e_1_2_6_24_2 doi: 10.1093/brain/117.5.1197 – ident: e_1_2_6_2_2 doi: 10.1001/archneur.1968.00470310034003 – ident: e_1_2_6_31_2 doi: 10.1007/978-3-7091-6641-3_7 – ident: e_1_2_6_22_2 doi: 10.1212/WNL.53.9.1969 – volume: 82 start-page: 135 year: 2000 ident: e_1_2_6_29_2 article-title: Alien limb sign publication-title: Adv Neurol contributor: fullname: Hanna PA – volume: 246 start-page: 1 issue: 2 year: 1999 ident: e_1_2_6_27_2 article-title: Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration publication-title: J Neurol contributor: fullname: Litvan I – ident: e_1_2_6_33_2 doi: 10.1111/jon199664222 – ident: e_1_2_6_34_2 doi: 10.1002/1531-8257(200003)15:2<340::AID-MDS1025>3.0.CO;2-O – ident: e_1_2_6_25_2 doi: 10.1002/mds.870120315 – ident: e_1_2_6_5_2 doi: 10.1136/jnnp.64.2.184 – ident: e_1_2_6_20_2 doi: 10.1212/WNL.40.8.1203 – volume: 11 start-page: 346 year: 1996 ident: e_1_2_6_13_2 article-title: Epidemiologic approaches to cortical‐basal ganglionic degeneration publication-title: Mov Disord contributor: fullname: Tanner CM – ident: e_1_2_6_10_2 doi: 10.1001/archneur.55.7.957 – ident: e_1_2_6_17_2 doi: 10.1002/mds.870050420 – ident: e_1_2_6_21_2 doi: 10.1093/brain/114.1.541 – volume: 82 start-page: 35 year: 2000 ident: e_1_2_6_32_2 article-title: Focal and asymmetric cortical degenerative syndromes publication-title: Adv Neurol contributor: fullname: Caselli RJ – volume: 11 start-page: 346 issue: 3 year: 1996 ident: e_1_2_6_30_2 article-title: A comparison of apraxia in Progressive supranuclear palsy and corticobasal ganglionic degeneration publication-title: Mov Disord contributor: fullname: Lindholm KM – start-page: 513 volume-title: Parkinson's disease and movement disorders year: 1998 ident: e_1_2_6_7_2 contributor: fullname: Jankovic J – ident: e_1_2_6_15_2 doi: 10.1093/brain/108.1.193 – volume: 82 start-page: 61 year: 2000 ident: e_1_2_6_12_2 article-title: Dystonia in corticobasal degeneration publication-title: Adv Neurol contributor: fullname: Vanek Z – ident: e_1_2_6_14_2 doi: 10.1212/WNL.48.4.959 – ident: e_1_2_6_26_2 doi: 10.1002/mds.870120419 – ident: e_1_2_6_28_2 doi: 10.1136/jnnp.55.9.806 – ident: e_1_2_6_11_2 doi: 10.1212/WNL.40.10.1571 – ident: e_1_2_6_4_2 doi: 10.1212/WNL.46.3.720 – ident: e_1_2_6_8_2 doi: 10.1093/brain/117.5.1183 – volume: 11 start-page: 346 year: 1996 ident: e_1_2_6_23_2 article-title: Cortical‐basal ganglia degeneration. Neurophysiology of stimulus‐sensitive myoclonus publication-title: Mov Disord contributor: fullname: Ashby P – volume: 11 start-page: 354 year: 1996 ident: e_1_2_6_3_2 article-title: Validity of clinical diagnosis of cortical‐basal ganglionic degeneration publication-title: Mov Disord contributor: fullname: Litvan I – start-page: 297 volume-title: Parkinson's disease and movement disorders year: 1998 ident: e_1_2_6_9_2 contributor: fullname: Kumar R – ident: e_1_2_6_18_2 doi: 10.1016/0022-510X(90)90271-N |
SSID | ssj0011516 |
Score | 1.9790487 |
Snippet | OBJECTIVE:
To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal... To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal degeneration (CBD).... Abstract OBJECTIVE: To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal... OBJECTIVE: To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal... |
SourceID | proquest crossref pubmed pascalfrancis wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 252 |
SubjectTerms | Adult Aged Anti-Dyskinesia Agents - therapeutic use Basal Ganglia - physiopathology Biological and medical sciences botulinum toxin Botulinum Toxins - therapeutic use Cerebral Cortex - physiopathology Contracture - epidemiology Contracture - etiology Contracture - physiopathology corticobasal degeneration Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dopamine Agonists - therapeutic use dystonia Dystonia - diagnosis Dystonia - drug therapy Dystonia - etiology Female Humans Levodopa - therapeutic use Male Medical sciences Middle Aged Muscle, Skeletal - physiopathology Neurodegenerative Diseases - complications Neurodegenerative Diseases - diagnosis Neurodegenerative Diseases - physiopathology Neurology Pain - epidemiology Pain - etiology Pain - physiopathology Retrospective Studies |
Title | Dystonia in corticobasal degeneration |
URI | https://api.istex.fr/ark:/67375/WNG-FF79BQDG-0/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.1038 https://www.ncbi.nlm.nih.gov/pubmed/11295777 https://search.proquest.com/docview/21166676 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA8yQXzx-6PqdIL61tmuabo-qnMbwgbqxIEPIWkTGcNO1g3Uv967dN2cKIhPeUlCLpfL_S65_ELIiWbScz0hbYGxCXU1HjT5ke27SgFiplQYUp9WmzUf6E3X706yKvEtTMYPMT1wQ8sw-zUauJDp-Yw09CVODbs3bL_Io4d46G7KHAU4x_x6CjbkmwfCOe-sUznPG855okWc1DfMjBQpTI7OfrX4CXbOo1jjhuqr5CkXIMs-6ZfHI1mOPr5xO_5PwjWyMkGnpYtsOa2TBZVskKXW5P59k5zW3hEs9kSpl5QgboVqsB-k0CRWz4bAGvW8RTr1685V0558tGBHFBy2DZiF4oWeL7XyFItCD5CXKxwI_iIhNZWhQKK5oOqykMW-ijR4ehVqpllIA-1tk0IySNQuKXmupCKMq_imgYYqrrKqjKhyA6115DjKIsf5nPPXjE6DZ8TJFQ7ichTXImdGGdMKYtjH9LPA54_tBq_Xg_DyttbgjkWKc9r60iPARAYdHeXa42A0eBMiEjUYpxyiXobJvRbZyZQ6awr4xwdRYRBGNb-Okrdq91ju_bXiPlme5a8dkMJoOFZFADQjeWiW7icbhe5w |
link.rule.ids | 315,786,790,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED51ILG9jF9j60ahSMBbICG202hPg9IWaCsBneABybITe0JoYaKtBPvruXOaliKQEE9-sS2fz-f7zj5_Bti0QodBqLSnKDZhgaWDJp54PDAGETNjypH6dLqi9ZsdX_LLEvws3sLk_BDjAzeyDLdfk4HTgfTuhDX0b9p39N4fYBatnZNV1s_G3FGIdNy_p2hF3D0RLphn_b3douWUL5qlab2n3EjVx-mx-b8WLwHPaRzrHFFjHq4KEfL8k5ud4UDvJP-fsTu-U8YF-DwCqNVf-YpahJLJlmCuM7qCX4at-gPhxWtVvc6qGLpiNdwS-tgkNX8chzWp-gv0Goe9g5Y3-mvBSxj6bA9hC6M7Pa6tCY1I4hDBV6B8jP8SpS3TsSKuuagWiFik3CQWnb2JrbAiZpENV2Amu83MN6iGgWYqTmv0rIHFJq2Jmk6YCSJrbeL7pgwbxaTLfzmjhsy5k_ckiitJ3DJsO22MK6i7G8pAi7i86DZloxHF-6f1pvTLUJlS15MeESkK7Gi9UJ9Eu6HLEJWZ22FfYuArKL-3DF9zrU6aIgTiKCoOwunm1VHKTv2cyu9vrbgOH1u9Tlu2j7onP-DTJJ1tFWYGd0NTQXwz0GtuHT8CEqPykA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9swED-NIlW8wD6hMGgmbXsLTRrHSR7ZQso-Wu2j0yrxYNmJjaqKFNFWYvvruXOadp02adqTX2zL5_P5fmeffwZ4abgK_EAqV1JswnxDB01h7oa-1oiYGZOW1Kc_4Bff2PtROFpmVdJbmIofYnXgRpZh92sy8JvCdNakodfFzLJ7b8E240GXAq_0y4o6CoGO_fYUjSi0L4Rr4lmv26lbbriibZrVO0qNlDOcHVN9a_En3LkJY60fyvbgspagSj-ZnC7m6jT_-Ru54_-J-BB2l_DUOavW0yN4oMvH0OwvL-CfwKv0B6HFsXTGpYOBK1bDDWGGTQp9ZRmsSdFPYZidD99euMufFtycocd2EbQwutELldGB5nkSIPTypYfRXy6VYSqRxDQXxT5PeBHq3KCr14nhhicsMsEzaJTTUh-AE_iKyaSI6VEDS3QR81jlTPuRMSb3PN2CF_Wci5uKT0NUzMldgeIKErcFr60yVhXk7YTyz6JQfB_0RJZFyZvPaU94LTje0NYvPSJO5NhRu9aeQKuhqxBZ6uliJjDs5ZTd24L9SqnrpgiAQhQVB2FV89dRin76lcrDf63YhuanNBMf3w0-HMHOOpftOTTmtwt9jOBmrk7sKr4HSJ7xPw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dystonia+in+corticobasal+degeneration&rft.jtitle=Movement+disorders&rft.au=Vanek%2C+Z&rft.au=Jankovic%2C+J&rft.date=2001-03-01&rft.issn=0885-3185&rft.volume=16&rft.issue=2&rft.spage=252&rft_id=info:doi/10.1002%2Fmds.1038&rft_id=info%3Apmid%2F11295777&rft.externalDocID=11295777 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon |